Cost effectiveness of different treatment strategies with natalizumab for pregnant women with multiple sclerosis.

Abstract

Background: The management of multiple sclerosis (MS) during pregnancy poses significant challenges. This study aimed to evaluate the cost-effectiveness of three natalizumab treatment strategies during pregnancy from the UK healthcare system's perspective.